The former Chief Digital Officer for New York City shares advice for how business leaders can best manage their personal media outlets.

Keep on reading: Top Social Media Tips for Execs

(MedPage Today) -- Calcium-channel blocker nasal spray etripamil flopped for rapid conversion of paroxysmal supraventricular tachycardia (PSVT) in its pivotal phase III trial, but the story may not be over for the novel agent. The novel agent...

A WAD of fake $50 notes has been splashed across southern Tasmania with police receiving 20 separate reports of the counterfeit currency.

Coronavirus concerns see low crowd numbers at the NT's NTFL grand final, where the Nightcliff Tigers make history winning back-to-back premierships in a first for the club, beating St Mary's by 13 points.

When Georgie Rowe hopped on her indoor rowing machine, she had no intention of breaking a world record. But she has just overtaken an Olympic gold medallist.

Todd Greenberg resigns with immediate effect after four years leading the NRL, in a decision the sporting body says was mutually agreed.

Queensland bicycle shops say they're having to turn customers away because of two-month delays on new stock, while overwhelming demand for repairs has them working 12-hour days.

Your Zoom or Skype meetings don't have to look like hostage videos. Here's what some experts advise.

The feature directing debut for actor Clark Duke, "Arkansas" amiably places Liam Hemsworth in a dangerous world of low-level criminals.

We chat with two movie vets featured on Disney+'s "Prop Culture": the director of "Honey, I Shrunk the Kids" and the animator of "The Nightmare Before Christmas."

The Maryland-based TV station owner's tactics in an aborted takeover of Tribune Media drew FCC scrutiny.

Medicaid and other parts of the healthcare safety net get left behind in the Trump administration's plans for distributing aid to battle the coronavirus.

A common cough syrup ingredient has pro-viral properties and should be avoided by people infected by the coronavirus, scientists warn.

Gradual easing of coronavirus restrictions brings hopes, fears

Since March, many ports are refusing to allow crew changes or shore leave.

Watch the timelapse of artist Lionel Stanhope creating his artwork under London's Waterloo Bridge.

Former NBA player Cliff Alexander -- the top H.S. recruit in the country in 2014 -- was arrested Wednesday ... after cops say they found a loaded gun on him during a traffic stop. TMZ Sports has learned ... Cliff was pulled over at around 9:30 PM…

The former Coronation Street star has sparked envy with her stunning decor

EBS is one of AWS’s primary storage services and is supported by a wide variety of functionalities, including built-in snapshot backups. We're sharing how you can use snapshots to maximize the value of your EBS services.

Keep on reading: 5 Ways EBS Snapshots Can Make Your Life Easier

Sharing third-party AWS workflow options that can be integrated to increase your operation's effectiveness and productivity when working in the cloud. 

Keep on reading: Automating the Cloud: AWS Tools and Tips

Advanced chemistry developed by Teknor Apex has yielded a new series of ThermoPlastic Elastomers (TPEs) for over-moulding that exhibit adhesion to engineering plastic substrates while meeting the requirements for use in medical devices.

Thermoformed packaging company Lacerta has managed to ship over three million Personal Protective Equipment (PPE) face shields to healthcare and frontline workers, in response to the coronavirus pandemic.

The experimental 5-HT1A receptor agonist and D2 receptor antagonist was not effective on primary or secondary endpoints

The genetic mutations that cause epilepsy don’t stop there. Praxis Precision Medicines CEO Marcio Souza says research also links these genes to other neurological conditions. The biotech startup is turning that research into new neuro drugs and it’s coming out of stealth to share details about its science and its pipeline, which already has two […]

Gilead has said that Dr John McHutchison is stepping down after nine years at the firm.

Gilead’s Chief Scientific Officer and Head of Research and Development has decided to leave the company next month, Gilead said.

Under McHutchinson, Gilead developed five new hepatitis drugs, which have been used by as many as 3.2 million people around the world.

read more

Chief Executive Mike Thompson is to retire from his role at the Association of the British Pharmaceutical Industry (ABPI) by the end of this year.

His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.

read more

Dr Reshma Kewalramani has been made the new Vertex CEO.

Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO Jeffrey Leiden who has is now stepping aside from the role after seven years as Chief executive at the Boston-based firm. In stepping down Leiden will serve as executive chairman until the first quarter of 2023.     

Fourty-six year old Dr Kewalramani, who has been at Vertex since 2017, will thus become the first woman to head the firm. Prior to joining Vertex, Kewalramani spent more than 12 years at Amgen.

read more

Chief Executive of Gulf Pharmaceutical Industries, Jerome Carle, is stepping down from his post at the United Arab Emirates drug manufacturer facing mounting pressure.

Julphar, one of the biggest generic drugs manufacturers in the Middle East and North Africa said Jerome Carle has “tendered his resignation” and the board has accepted it. His last working day will be December 8th.

read more

Ipsen has named Dr Steven Hildemann as its new Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance.

In his new role, which begins on 1 March 2020 and will be based in Paris, he will report directly to Ipsen CEO Aymeric Le Chatelier. His remit will include the provision of medical strategy to the company’s scientific, clinical and business teams, while also working in tandem with its R&D operations to design and direct clinical trials efforts to generation of post-launch data.

read more

The Japanese pharma development firm will harness risk-based quality management solutions to help sponsors improve trial quality and safety.

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Republican Arizona Governor Doug Ducey urging the wider use of hydroxychloroquine, based on data they have collected.

Click to view a price quote on TLRY.

US drugmaker Alexion Pharmaceuticals fared better in its revenue and adjusted earnings figures in the…

Amgen’s Otezla (apremilast), a drug divested by Celgene ahead of its acquisition by Bristol-Myers Squibb,…

Italian drugmaker Recordati has reported consolidated revenues for the first quarter of 2020 are 429.2…

Novartis is using familiar faces—real patients from its Cosentyx TV commercials—to thank healthcare workers and promise support for patients. It’s a shift away from product-centered TV ads as Novartis adjusts its Cosentyx DTC effort during the COVID-19 crisis to highlight resources for patients, the drugmaker said.

Amgen is planning to file for FDA approval of Otezla in mild to moderate plaque psoriasis based on new data showing patients on the drug experienced significant improvements in their symptoms. The label expansion will be key to Amgen's ability to recoup the $13.4 billion it paid to acquire the drug from Celgene last year.

When Gilead Sciences scored a groundbreaking FDA emergency use authorization for COVID-19 therapy remdesivir, the company made the unusual move of handing distribution rights to the U.S. government. But the federal rollout has gotten off to a rocky start. 

The Department today filed suit against Ronald D. Peterson and Glen E. Johnson, the owner and rental manager, respectively, of 11 single family homes in Ypsilanti, Mich., alleging a pattern or practice of sexual harassment of female tenants.

Timothy Oldani, 24, of Scott Depot, W.Va., and Joseph Oldani, 21, of Camp Lejeune, N.C., both pleaded guilty today in the Southern District of West Virginia to conspiring to steal military optics from the U.S. Marine Corps and illegally export them from the United States.

A former contract employee of the U.S. Army Corps of Engineers and a dirt, sand and gravel subcontractor were both convicted on charges of conspiracy and bribery in connection with a $16 million hurricane protection project for the reconstruction of the Lake Cataouatche Levee, south of New Orleans.

The Department announced the filing of a lawsuit in U.S. District Court in Salt Lake City on behalf of Jose A. Ortega, a Utah National Guard member, against Synapse Data and Telecom Inc., and Matthew Mossbarger, Synapse’s owner and operator, alleging violations of the Uniformed Services Employment and Reemployment Rights Act of 1994 (USERRA).

The owner of a Costa Rica-based telemarketing call center and two employees of another Costa Rica call center were sentenced for their roles in schemes that targeted and defrauded thousands of American victims of more than $10 million.

"These COPS grants we are announcing today help fulfill President Obama and Vice President Biden’s commitment to meet the challenges of our struggling economy with solutions that will keep our country safe and keep us moving forward."

"I stand here to celebrate the more than $12 million that has been awarded to the D.C. Metropolitan Police Department to fund the hiring and rehiring of 50 law enforcement officers in the District. These funds will provide 100 percent of the approved salary and benefits for these officers for three years, and all police departments receiving the grants will then be required to retain the grant-funded positions for a fourth year."

Seven individuals from around New England have been indicted in federal court in Boston for conspiracies to defraud the United States through the promotion and use of multiple tax fraud schemes.

Japanese electronics manufacturer Epson Imaging Devices Corporation (Epson) agreed to plead guilty and pay a $26 million criminal fine for its role in a conspiracy to fix prices in the sale of Thin Film Transistor-Liquid Crystal Display panels (TFT-LCD) sold to Motorola Inc.